BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26832220)

  • 1. Effects of a novel carbocyclic analog of pyrrolo[2,3-d]pyrimidine nucleoside on pleiotropic induction of cell death in prostate cancer cells with different androgen responsiveness.
    Suh H; Choi KW; Lee J; Ryou C; Rhee H; Lee CH
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1130-5. PubMed ID: 26832220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21CIP1 Induces Apoptosis via Binding to BCL2 in LNCaP Prostate Cancer Cells Treated with MCS-C3, A Novel Carbocyclic Analog of Pyrrolopyrimidine.
    Choi KW; Suh H; Oh HL; Ryou C; Lee CH
    Anticancer Res; 2016 Jan; 36(1):213-20. PubMed ID: 26722046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benzyldihydroxyoctenone, a novel nonsteroidal antiandrogen, shows differential apoptotic induction in prostate cancer cells in response to their androgen responsiveness.
    Suh H; Oh HL; Lee CH
    J Microbiol Biotechnol; 2011 May; 21(5):540-4. PubMed ID: 21617354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel histone deacetylase (HDAC) inhibitor MHY219 induces apoptosis via up-regulation of androgen receptor expression in human prostate cancer cells.
    Patra N; De U; Kim TH; Lee YJ; Ahn MY; Kim ND; Yoon JH; Choi WS; Moon HR; Lee BM; Kim HS
    Biomed Pharmacother; 2013 Jun; 67(5):407-15. PubMed ID: 23583193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK.
    Xiao L; Eto M; Kazanietz MG
    J Biol Chem; 2009 Oct; 284(43):29365-75. PubMed ID: 19667069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3 Kinase inhibition on TRAIL-induced apoptosis correlates with androgen-sensitivity and p21 expression in prostate cancer cells.
    Kadowaki Y; Chari NS; Teo AE; Hashi A; Spurgers KB; McDonnell TJ
    Apoptosis; 2011 Jun; 16(6):627-35. PubMed ID: 21437722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bisbibenzyls, novel proteasome inhibitors, suppress androgen receptor transcriptional activity and expression accompanied by activation of autophagy in prostate cancer LNCaP cells.
    Hu Z; Zhang D; Wang D; Sun B; Safoor A; Young CY; Lou H; Yuan H
    Pharm Biol; 2016; 54(2):364-74. PubMed ID: 26017567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy.
    Ouyang DY; Zeng LH; Pan H; Xu LH; Wang Y; Liu KP; He XH
    Food Chem Toxicol; 2013 Oct; 60():424-30. PubMed ID: 23939040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells.
    Hååg P; Bektic J; Bartsch G; Klocker H; Eder IE
    J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):251-8. PubMed ID: 15982869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.
    Yim D; Singh RP; Agarwal C; Lee S; Chi H; Agarwal R
    Cancer Res; 2005 Feb; 65(3):1035-44. PubMed ID: 15705905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell cycle arrest and apoptotic induction in LNCaP cells by MCS-C2, novel cyclin-dependent kinase inhibitor, through p53/p21WAF1/CIP1 pathway.
    Park HY; Kim MK; Moon SI; Cho YH; Lee CH
    Cancer Sci; 2006 May; 97(5):430-6. PubMed ID: 16630142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VMY-1-103, a dansylated analog of purvalanol B, induces caspase-3-dependent apoptosis in LNCaP prostate cancer cells.
    Ringer L; Sirajuddin P; Yenugonda VM; Ghosh A; Divito K; Trabosh V; Patel Y; Brophy A; Grindrod S; Lisanti MP; Rosenthal D; Brown ML; Avantaggiati ML; Rodriguez O; Albanese C
    Cancer Biol Ther; 2010 Aug; 10(4):320-5. PubMed ID: 20574155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HY251, a novel decahydrocyclopenta[a]indene analog, from Aralia continentalis induces apoptosis via down-regulation of AR expression in human prostate cancer LNCaP cells.
    Oh HL; Lee CH
    Bioorg Med Chem Lett; 2011 Mar; 21(5):1347-9. PubMed ID: 21315590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ERRgamma suppresses cell proliferation and tumor growth of androgen-sensitive and androgen-insensitive prostate cancer cells and its implication as a therapeutic target for prostate cancer.
    Yu S; Wang X; Ng CF; Chen S; Chan FL
    Cancer Res; 2007 May; 67(10):4904-14. PubMed ID: 17510420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of cell death induced by histone deacetylase inhibitors in androgen receptor-positive prostate cancer cells.
    Rokhlin OW; Glover RB; Guseva NV; Taghiyev AF; Kohlgraf KG; Cohen MB
    Mol Cancer Res; 2006 Feb; 4(2):113-23. PubMed ID: 16513842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxol-induced growth arrest and apoptosis is associated with the upregulation of the Cdk inhibitor, p21WAF1/CIP1, in human breast cancer cells.
    Choi YH; Yoo YH
    Oncol Rep; 2012 Dec; 28(6):2163-9. PubMed ID: 23023313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP
    Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of polyamine catabolic enzymes involved in diverse responses against epibrassinolide-induced apoptosis in LNCaP and DU145 prostate cancer cell lines.
    Obakan P; Arisan ED; Calcabrini A; Agostinelli E; Bolkent S; Palavan-Unsal N
    Amino Acids; 2014 Mar; 46(3):553-64. PubMed ID: 23963538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.
    Li L; Zhu Z; Joshi B; Porter AT; Tang DG
    Anticancer Res; 1999; 19(1A):51-60. PubMed ID: 10226524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.